Houston-based LogoBar has created an advertising model that doesn't annoy the viewers. Getty Images

Steven Jones knows people dislike ads. Actually, he reasons, it's less that they dislike ads, but more that they don't like having those ads interrupt what they're doing.

"They want to be in control of their experience," he says. "And we've nearly always had things that allow consumers to skip ads – the remote control, where you could change the channel; now there are DVRs that let you skip them. That's all about control."

Jones knows, however, that consumers do want the information ads contain. And he thinks one of the best ways to give that to them in this splintered and ever-changing media environment is for advertisers to concede that concept of audience control. That's what LogoBar aims to do. Where a traditional commercial on television or before an online video might be 15 or 30 seconds, LogoBar features a company's logo or a product it's selling at the bottom of the video. The ad or logo will also appear when the viewer hits pause (or some other engagement) on the video. The viewer, if interested in the product can then choose to engage with it by clicking on the offer that's being advertised or on the product itself, which would then take that viewer to the advertiser's site.

The goal, says Jones, is two-fold: get the products and services in front of potential buyers, and allow those buyers to be the ones who determine if they want to engage.

"It's not intrusive at all," says Jones about the concept. "It allows a brand to be seen, which can spur interest. But keeping control in the hands of the intended audience is the key. This allows advertisers to think about their brands as a call to action. And this method of delivery aligns with the experience the viewer is already having."

Jones realizes that many people view ads as interruptions. He says that one of the reasons Google began making three-second ads right about 2015 was to capture on the shortening attention span of viewers who, he says studies show, were looking to skip ads the second they appeared.

LogoBar created digital technology that allows its clients to create its own ads. LogoBar installs the tech and then the client's team can build on it. But LogoBar can also create the advertising from end to end as well. The tech plugins work across multiple platforms including Brightcove, Kaltura, Flowplayer, and native iOS/Android players. By building that compatibility into its technology, Jones says that LogoBar can be easily and widely used.

"I think of us as still being an early startup," he says of the company. "But we have a strong team of five here, and I see us growing the business and the team across the next few years."

LogoBar has worked with ESPN+ and other local and national clients. And he believes LogoBar is poised to create what thinks of as a win-win for consumers and advertisers alike.

"Firms are still creating 30, 60-second 'stories' in their ads. Those aren't going to go away. And people will watch them – when they want to, on their own time. What we're offering is something that complements traditional advertising and gives consumers both an interactive experience and control over their viewing and time."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Rice University lands $18M to revolutionize lymphatic disease detection

fresh funding

An arm of the U.S. Department of Health and Human Services has awarded $18 million to scientists at Rice University for research that has the potential to revolutionize how lymphatic diseases are detected and help increase survivability.

The lymphatic system is the network of vessels all over the body that help eliminate waste, absorb fat and maintain fluid balance. Diseases in this system are often difficult to detect early due to the small size of the vessels and the invasiveness of biopsy testing. Though survival rates of lymph disease have skyrocketed in the United States over the last five years, it still claims around 200,000 people in the country annually.

Early detection of complex lymphatic anomalies (CLAs) and lymphedema is essential in increasing successful treatment rates. That’s where Rice University’s SynthX Center, directed by Han Xiao and Lei Li, an assistant professor of electrical and computer engineering, comes in.

Aided by researchers from Texas Children’s Hospital, Baylor College of Medicine, the University of Texas at Dallas and the University of Texas Southwestern Medical Center, the center is pioneering two technologies: the Visual Imaging System for Tracing and Analyzing Lymphatics with Photoacoustics (VISTA-LYMPH) and Digital Plasmonic Nanobubble Detection for Protein (DIAMOND-P).

Simply put, VISTA-LYMPH uses photoacoustic tomography (PAT), a combination of light and sound, to more accurately map the tiny vessels of the lymphatic system. The process is more effective than diagnostic tools that use only light or sound, independent of one another. The research award is through the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics and pHenotyping Technologies (LIGHT) program, part of the U.S. HHS, which saw the potential of VISTA-LYMPH in animal tests that produced finely detailed diagnostic maps.

“Thanks to ARPA-H’s award, we will build the most advanced PAT system to image the body’s lymphatic network with unprecedented resolution and speed, enabling earlier and more accurate diagnosis,” Li said in a news release.

Meanwhile, DIAMOND-P could replace the older, less exact immunoassay. It uses laser-heated vapors of plasmonic nanoparticles to detect viruses without having to separate or amplify, and at room temperature, greatly simplifying the process. This is an important part of greater diagnosis because even with VISTA-LYMPH’s greater imaging accuracy, many lymphatic diseases still do not appear. Detecting biological markers is still necessary.

According to Rice, the efforts will help address lymphatic disorders, including Gorham-Stout disease, kaposiform lymphangiomatosis and generalized lymphatic anomaly. They also could help manage conditions associated with lymphatic dysfunction, including cancer metastasis, cardiovascular disease and neurodegeneration.

“By validating VISTA-LYMPH and DIAMOND-P in both preclinical and clinical settings, the team aims to establish a comprehensive diagnostic pipeline for lymphatic diseases and potentially beyond,” Xiao added in the release.

The ARPA-H award funds the project for up to five years.

Houston doctor wins NIH grant to test virtual reality for ICU delirium

Virtual healing

Think of it like a reverse version of The Matrix. A person wakes up in a hospital bed and gets plugged into a virtual reality game world in order to heal.

While it may sound far-fetched, Dr. Hina Faisal, a Houston Methodist critical care specialist in the Department of Surgery, was recently awarded a $242,000 grant from the National Institute of Health to test the effects of VR games on patients coming out of major surgery in the intensive care unit (ICU).

The five-year study will focus on older patients using mental stimulation techniques to reduce incidences of delirium. The award comes courtesy of the National Institute on Aging K76 Paul B. Beeson Emerging Leaders Career Development Award in Aging.

“As the population of older adults continues to grow, the need for effective, scalable interventions to prevent postoperative complications like delirium is more important than ever,” Faisal said in a news release.

ICU delirium is a serious condition that can lead to major complications and even death. Roughly 87 percent of patients who undergo major surgery involving intubation will experience some form of delirium coming out of anesthesia. Causes can range from infection to drug reactions. While many cases are mild, prolonged ICU delirium may prevent a patient from following medical advice or even cause them to hurt themselves.

Using VR games to treat delirium is a rapidly emerging and exciting branch of medicine. Studies show that VR games can help promote mental activity, memory and cognitive function. However, the full benefits are currently unknown as studies have been hampered by small patient populations.

Faisal believes that half of all ICU delirium cases are preventable through VR treatment. Currently, a general lack of knowledge and resources has been holding back the advancement of the treatment.

Hopefully, the work of Faisal in one of the busiest medical cities in the world can alleviate that problem as she spends the next half-decade plugging patients into games to aid in their healing.